dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Cardiology Homepage

Saudi Arabia Ministry of Health and Masimo to automate national neonatal CCHD screening process using Masimo technology

Record number of late-breaking trials submitted to EHRA 2019 Congress

Novel PET/CT imaging agent shows promise for safe and effective diagnosis of acute venous thromboembolism

Foldax, Inc. gains approval to begin US clinical trials of the first and only biopolymer heart valve platform

Medtronic and Medical University of South Carolina partner to improve patient outcomes

Novel software offers possible reduction in arrhythmic heart disease

Texas Cardiac Arrhythmia Institute first in U.S. to treat patient in study to evaluate balloon ablation for atrial fibrillation

Corindus announces FDA submission for neurovascular intervention indication for CorPath GRX vascular robotic system

GE Healthcare and Preventice Solutions collaborate to connect the heart, the hospital and the home seamlessly

MaxQ accelerates artificial intelligence performance with Intel

Cardiac Insight gets FDA clearance for CARDEA SOLO, wearable ECG sensor

Press releases may be edited for formatting or style
April 20, 2017, KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Insight, a U.S. developer of body worn sensing devices and computational software, announced today, the FDA has cleared the company’s wearable electrocardiogram (ECG) sensor, CARDEA SOLO™. The device offers physicians immediate access to improved reporting and analysis of heartbeat-to-heartbeat data. The design and ease of use also encourage better patient compliance for the acquisition and recording of complete patient data. CARDEA SOLO will be used to assist with the diagnosis of a variety of arrhythmias, including the most common, atrial fibrillation (AFib).

The company expects the capabilities of CARDEA SOLO to enhance efficiencies in mean time to cardiac diagnosis and treatment, which can contribute to improved conditions for patients and reduce health care system costs.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510



“CARDEA SOLO is an affordable, patient friendly and nonintrusive device designed to improve health care for the millions of patients who suffer from arrhythmia,” said Brad Harlow, Co-Founder and Chief Executive Officer of Cardiac Insight, Inc. “The timely retrieval of cardiac patient data can contribute to improved diagnosis and treatment and lower health care costs.”

Physicians can now use CARDEA SOLO in their offices to retrieve full-disclosure cardiac data for immediate review and action - a process that previously required days or weeks. For the first time, the sensor technology eliminates the need for outsourcing to costly and time-consuming third-party service centers and puts control of the patient data, analysis and processing in the hands of physicians and their staff. Global service billing is streamlined and the need to track and reprocess in-house capital equipment is eliminated.

The device is small, lightweight (approximately 25 grams), lead-less, water-resistant and single-use disposable. Patients can wear CARDEA SOLO comfortably under their clothing for up to seven days and maintain their normal daily activities.

The CARDEA SOLO sensor records ECG data and patient symptoms. The physician office software analyzes the recorded cardiac data to provide physicians with full-disclosure of all data, ECG trace review tools and a summary report of heart rhythms.

The American Heart Association journal, Circulation, reported that 33.5 million people around the globe have AFib. According to the National Stroke Association, AFib raises a person's risk for stroke by 500 percent and most AFib-related strokes can be prevented.

CARDEA SOLO is available by contacting info@cardiacinsightinc.com.


About Cardiac Insight:
Cardiac Insight, Inc. (www.cardiacinsightinc.com) is a U.S. developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex disease states. The company’s technologies and systems are created using advanced algorithms and software that provide improvements in mean time to diagnosis. Cardiac Insight’s mission is to invent complete and progressive solutions for unmet clinical needs on behalf of physicians, clients and payers. Cardiac Insight was founded in 2008 and is based in Kirkland, WA.

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED